Biotech · Private company
Oncotherapeutics
Track this companyFree. Adds Oncotherapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials114 recruiting or active
Pipeline programs26From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline26
- Ascorbic acidPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- BTZPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CarfilzomibPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CFZPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CLAPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- ElotuzumabPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- IxazomibPhase 2 · Newly Diagnosed Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- LenalidomidePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- LenalidomidePhase 2 · Newly Diagnosed Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- MelphalanPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- MethylprednisolonePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- PLDPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- POMPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- PomalidomidePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- PrednisonePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- SteroidsPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 2 · Multiple Myeloma in RelapseClinicalTrials.gov · fetched Nov 12, 2026
- LenalidomidePhase 1 · Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- MethylprednisolonePhase 1 · Multiple Myeloma in RelapseClinicalTrials.gov · fetched Nov 12, 2026
- MethylprednisolonePhase 1 · Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- RuxolitinibPhase 1 · Multiple Myeloma in RelapseClinicalTrials.gov · fetched Nov 12, 2026
- Ruxolitinib Oral Tablet [Jakafi]Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- SelinexorPhase 1 · Multiple Myeloma in RelapseClinicalTrials.gov · fetched Nov 12, 2026
- SelinexorPhase 1 · Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- A Trial of Selinexor, Ruxolitinib and MethylprednisolonePHASE1 · RECRUITING · started Aug 6, 2024ClinicalTrials.gov NCT06225310 · fetched Nov 12, 2026
- A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple MyelomaPHASE2 · RECRUITING · started Jun 20, 2024ClinicalTrials.gov NCT06115135 · fetched Nov 12, 2026
- Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple MyelomaEARLY_PHASE1 · RECRUITING · started Dec 8, 2022ClinicalTrials.gov NCT06209606 · fetched Nov 12, 2026
- Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.PHASE1 · UNKNOWN · started Nov 1, 2020ClinicalTrials.gov NCT04519476 · fetched Nov 12, 2026
- Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM PatientsPHASE2 · TERMINATED · started Mar 1, 2019ClinicalTrials.gov NCT03733691 · fetched Nov 12, 2026
- Combination Study for High Risk Multiple Myeloma PatientsPHASE2 · TERMINATED · started Mar 13, 2017ClinicalTrials.gov NCT03104270 · fetched Nov 12, 2026
- A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) PatientsPHASE1 · RECRUITING · started Feb 1, 2017ClinicalTrials.gov NCT03110822 · fetched Nov 12, 2026
- Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 CarfilzomibPHASE2 · TERMINATED · started Dec 1, 2014ClinicalTrials.gov NCT02294357 · fetched Nov 12, 2026
- Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid TumorsPHASE1 · COMPLETED · started Nov 1, 2014ClinicalTrials.gov NCT02285101 · fetched Nov 12, 2026
- Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma PatientsPHASE1_PHASE2 · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02206425 · fetched Nov 12, 2026
- Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma PatientsPHASE2 · TERMINATED · started Jul 7, 2014ClinicalTrials.gov NCT02188368 · fetched Nov 12, 2026